The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Zimmer Biomet apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Zimmer Biomet overview

Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company that focuses on musculoskeletal healthcare. The company designs manufacture and markets orthopedic reconstructive products; biologics, sports medicine, extremities, and trauma products; suite of integrated digital and robotic technologies; craniomaxillofacial and thoracic products; office-based technologies; and associated surgical products. Its products and solutions assist in treating patients suffering from disorders or injuries of bones, joints, and supporting soft tissues. Zimmer Biomet offers products to orthopedic surgeons, neurosurgeons, other specialists, stocking distributors, hospitals, healthcare dealers, and healthcare purchasing organizations. The company markets its products through direct sales channels and distributors in the Americas, Europe, Asia-Pacific, the Middle East, and Africa. Zimmer Biomet is headquartered in Warsaw, Indiana, the US.

For a complete picture of G7, Hip Reconstruction pricing in the US, buy the report here.